Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mujeeb

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 18, 2025
Local controlled release of stabilized monoclonal antibodiesRae Sung Chang, Jennifer Walker, Anzar A Mujeeb, et al.
Advanced Therapeutics|November 22, 2024
Controlled Delivery of Paclitaxel via Stable Synthetic Protein NanoparticlesAva Mauser, Isabel Waibel, Kaushik Banerjee, et al.
Small (Weinheim an Der Bergstrasse, Germany)|April 18, 2025
HDL Nanodiscs Loaded with Liver X Receptor Agonist Decreases Tumor Burden and Mediates Long-term Survival in Mouse Glioma ModelTroy A Halseth, Anzar A Mujeeb, Lisha Liu, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
HDL Nanodiscs Loaded with Liver X Receptor Agonist Decreases Tumor Burden and Mediates Long-term Survival in Mouse Glioma ModelTroy A Halseth, Anzar A Mujeeb, Lisha Liu, et al.
Journal of Cellular Physiology|August 20, 2005
Microtubule-dependent nuclear-cytoplasmic shuttling of Runx2Shirwin M Pockwinse, Arun Rajgopal, Daniel W Young, et al.
Frontiers in Pharmacology|June 4, 2021
Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical DevelopmentsMahmoud S Alghamri, Brandon L McClellan, Carson S Hartlage, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
MIF-mediated reprogramming of myeloid lineage within the glioma tumor microenvironment impacts the efficacy of immune stimulatory gene therapyZiwen Zhu, Noah C Kanis, Anthony E George, et al.
Biorxiv : the Preprint Server for Biology|September 24, 2024
CD200 depletion in glioma enhances antitumor immunity and induces tumor rejectionItay Raphael, Anzar A Mujeeb, Elisabet Ampudia-Mesias, et al.
Molecular Therapy. Oncology|May 22, 2026
Reprogramming the immune suppressive tumor microenvironment in glioma enhances the efficacy of immune-mediated gene therapyBrandon L McClellan, Jorge A Peña Agudelo, Anzar A Mujeeb, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Reprogramming the Immune Suppressive Tumor Microenvironment in Glioma Enhances the Efficacy of Immune-Mediated Gene TherapyBrandon L McClellan, Jorge A Peña Agudelo, Anzar A Mujeeb, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 18, 2025
Local controlled release of stabilized monoclonal antibodiesRae Sung Chang, Jennifer Walker, Anzar A Mujeeb, et al.
Advanced Therapeutics|November 22, 2024
Controlled Delivery of Paclitaxel via Stable Synthetic Protein NanoparticlesAva Mauser, Isabel Waibel, Kaushik Banerjee, et al.
Small (Weinheim an Der Bergstrasse, Germany)|April 18, 2025
HDL Nanodiscs Loaded with Liver X Receptor Agonist Decreases Tumor Burden and Mediates Long-term Survival in Mouse Glioma ModelTroy A Halseth, Anzar A Mujeeb, Lisha Liu, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
HDL Nanodiscs Loaded with Liver X Receptor Agonist Decreases Tumor Burden and Mediates Long-term Survival in Mouse Glioma ModelTroy A Halseth, Anzar A Mujeeb, Lisha Liu, et al.
Journal of Cellular Physiology|August 20, 2005
Microtubule-dependent nuclear-cytoplasmic shuttling of Runx2Shirwin M Pockwinse, Arun Rajgopal, Daniel W Young, et al.
Frontiers in Pharmacology|June 4, 2021
Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical DevelopmentsMahmoud S Alghamri, Brandon L McClellan, Carson S Hartlage, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
MIF-mediated reprogramming of myeloid lineage within the glioma tumor microenvironment impacts the efficacy of immune stimulatory gene therapyZiwen Zhu, Noah C Kanis, Anthony E George, et al.
Biorxiv : the Preprint Server for Biology|September 24, 2024
CD200 depletion in glioma enhances antitumor immunity and induces tumor rejectionItay Raphael, Anzar A Mujeeb, Elisabet Ampudia-Mesias, et al.
Molecular Therapy. Oncology|May 22, 2026
Reprogramming the immune suppressive tumor microenvironment in glioma enhances the efficacy of immune-mediated gene therapyBrandon L McClellan, Jorge A Peña Agudelo, Anzar A Mujeeb, et al.
Biorxiv : the Preprint Server for Biology|November 26, 2025
Reprogramming the Immune Suppressive Tumor Microenvironment in Glioma Enhances the Efficacy of Immune-Mediated Gene TherapyBrandon L McClellan, Jorge A Peña Agudelo, Anzar A Mujeeb, et al.
Pageof 9